# Vitamin D3 (Cholecalciferol) - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: Enhance your mood and bolster your immune defenses today with Vitamin D3, a critical prohormone that also supports long-term bone density and cellular health.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **86/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 73/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 92/100 (Higher is safer)
- **Time Burden**: ~15 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 3/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Converts to calcitriol in the kidneys, which binds to the nuclear Vitamin D Receptor (VDR), directly regulating the transcription of ~5% of the human genome.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **82/100** [Rank #31 of 133 in Heart] - Effect: Prevents arterial calcification by carboxylating Matrix Gla Protein (MGP)
    - Mechanism: Carboxylates Matrix Gla Protein (MGP), the strongest endogenous inhibitor of vascular soft-tissue and coronary arterial calcification.
- **Bone Density & Connective Matrix**: **93/100** [Rank #5 of 142 in Bone Matrix] - Effect: Significantly increases bone mineral density and decreases age-related bone mineral loss
    - Mechanism: Vitamin D3 upregulates intestinal calcium absorption proteins while Vitamin K2 (Menaquinone-7) serves as the obligate co-factor for gamma-glutamyl carboxylase, activating osteocalcin to bind calcium into hydroxyapatite.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 2000-5000 IU
- **Recommended Timing**: Morning (with fat)
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: mood, cellular_longevity, energy, strength, bone_density, heart_health

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: None reported in standard human trials with recommended doses.
- **Safety Profile**: low_risk - Well tolerated within physiological ranges.

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Effect of vitamin D supplementation on depression: A systematic review and meta-analysis of randomized controlled trials** [PMID: 31805978]
   - Link: https://pubmed.ncbi.nlm.nih.gov/31805978/
2. **Effect of vitamin D supplementation in patients with chronic fatigue syndrome: a randomized controlled trial** [PMID: 27825208]
   - Link: https://pubmed.ncbi.nlm.nih.gov/27825208/
3. **The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials** [PMID: 27840933]
   - Link: https://pubmed.ncbi.nlm.nih.gov/27840933/
4. **Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women** [PMID: 23525894]
   - Link: https://pubmed.ncbi.nlm.nih.gov/23525894/
5. **The synergistic interrelationship between Vitamin D and Vitamin K for bone and cardiovascular health** [PMID: 31530136]
   - Link: https://pubmed.ncbi.nlm.nih.gov/31530136/
6. **Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women** [PMID: 25694037]
   - Link: https://pubmed.ncbi.nlm.nih.gov/25694037/
7. **Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data** [PMID: 28202713]
   - Link: https://pubmed.ncbi.nlm.nih.gov/28202713/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [Vitamin D3 (Cholecalciferol) on LongevityReviews](https://longevityreviews.org/modalities/vitamin-d3)
- **Last Evidence Calibration**: 2026-08-04
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.